BMJ  2007;335:1221-1222 (15 December), doi:10.1136/bmj.39400.376424.BE

Editorials

Regulation of drugs for children in Europe

New legislation encourages the drug industry to produce high quality transparent research

The first 150 words of the full text of this article appear below.

Over the past 10 years, studies have shown widespread use of unlicensed and off-label drugs to treat children in hospital and in the community.1 2 A prospective European study showed that two thirds of children in hospital received at least one unlicensed or off-label drug, and almost half of all drug prescriptions for these children were either unlicensed or off label.1 Subsequent studies confirmed that the use of unlicensed and off-label drugs is more likely to be associated with drug toxicity.3

In 1999, concerns were raised about children in Europe receiving unlicensed or off-label drugs instead of ones that have been scientifically evaluated and licensed.4 In December 2006, after extensive consultation, the European parliament approved legislation that should improve the regulation of drug treatment for children (regulation number 1901/2006 on medicinal products for paediatric use).

The legislation aims to ensure that drugs used for children are subject to high quality research . . . [Full text of this article]

Imti Choonara, professor in child health

1 Academic Division of Child Health, University of Nottingham, Derbyshire Children’s Hospital, Derby DE22 3DT

imti.choonara@nottingham.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Bua, J, L'Erario, I, Barbi, E, Marchetti, F (2008). When off-label is a good practice: the example of paracetamol and salbutamol. Arch. Dis. Child. 93: 546-547 [Full text]  

Rapid Responses:

Read all Rapid Responses

European Regulation for Children in Europe
Imran Mushtaq
bmj.com, 15 Dec 2007 [Full text]
Drugs for children in Europe: defining off-label priorities
Jenny Bua, et al.
bmj.com, 17 Dec 2007 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview